Master's Programme in Biopharmaceuticals

Education facts

Code: FBL2M

Are you fascinated by innovative medical breakthroughs like next-generation vaccines, gene and cell therapies, or life-changing immunotherapies? These innovations are part of the rapidly evolving world of biopharmaceuticals - also known as biologics or biological drugs – a dynamic and expanding frontier in science and pharmaceutical industry. Join our Master's programme in Biopharmaceuticals, which offers a unique opportunity to explore the *entire journey* of a biopharmaceutical product - from its initial design and molecular development, through production, analysis, and pre-clinical testing using advanced methods and techniques, all the way to clinical testing and real-world use. Our Master’s programme is tightly integrated with ongoing research on biopharmaceuticals at Uppsala University and closely connected to the thriving biotech ecosystem of Uppsala. As a student, you will experience hands-on, research-driven learning, and are given the opportunity to complete your Master’s thesis either within one of Uppsala University's cutting-edge research labs, at a partner university, with a regulatory agency, or inside an innovative biotech company. You will gain valuable knowledge and experience that pave the way for a career in academic research, the global biopharma industry, or regulatory and intellectual property sectors. All courses are taught in English.

Entry requirements

_Academic requirements_ A Bachelor's degree, equivalent to a Swedish Kandidatexamen, from an internationally recognised university. Also required is 90 credits in in one or a combination of the following subjects: pharmaceutical sciences, cell biology, biotechnology, physiology, biomedicine, chemistry, biology. _Language requirements_ Proficiency in English equivalent to the Swedish upper secondary course English 6. This requirement can be met either by achieving the required score on an internationally recognised test, or by previous upper secondary or university studies in some countries. Detailed instructions on how to provide evidence of your English proficiency are available at [universityadmissions.se](https://www.universityadmissions.se/en/entry-requirements/english-language-requirements/).

Education offerings

Each offering has its own dates and conditions. Closed offerings are retained as history and do not mean that a new application is open.

• Master's Programme in Biopharmaceuticals

  Uppsala University

  Start date: 31 August 2026

  End date: 4 June 2028

  Pace of study: 100 %